Literature DB >> 33449244

Epilepsy and quality of life: what does really matter?

Mario Tombini1, Giovanni Assenza2, Livia Quintiliani3, Lorenzo Ricci2, Jacopo Lanzone2, Vincenzo Di Lazzaro2.   

Abstract

PURPOSE: To assess quality of life (QoL) in adult people with epilepsy (PWE) and identify the main factors affecting it.
METHODS: We enrolled consecutively 122 PWE. They were interviewed for a careful collection of demographic and clinical data. Patients completed dedicated questionnaires for the assessment of the quality of life (Quality of Life in Epilepsy Scale-31) (Q31) as well as psychosocial features: depressive symptoms (DS) (Beck Depression Inventory-II/BDI-II), difficulties of emotion regulation (Difficulties of Emotion Regulation Scale/DERS), and stigma related to epilepsy (Stigma Scale of Epilepsy/SSE and Jacoby's Stigma Scale/JSS). The results of Q31 and their subscales were correlated with clinical details of PWE, as well as the other scores. A stepwise multiple regression analysis was applied to identify the main factors affecting QoL.
RESULTS: Quality of life is inversely correlated mostly with psychosocial features, as DS, emotion dysregulation, and stigma perception, as well as with epilepsy-related factors, as the seizure frequency and number of antiseizure medications (ASMs). The combination of DS, perceived stigma, and number of ASMs best explained the QoL. Worse features of QoL were detected in females and in patients with age of epilepsy onset in adulthood.
CONCLUSION: Quality of life in adult PWE is predominantly affected by psychosocial factors more than epilepsy-related ones. These findings suggest that effective epilepsy management requires more than seizure control, and early detection of psychological dysfunction and tailored interventions to improve the QoL should be considered.

Entities:  

Keywords:  Depressive symptoms; Epilepsy; Psychosocial factors; Quality of life; Stigma

Year:  2021        PMID: 33449244     DOI: 10.1007/s10072-020-04990-6

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  31 in total

1.  Development and cross-cultural translations of a 31-item quality of life in epilepsy inventory.

Authors:  J A Cramer; K Perrine; O Devinsky; L Bryant-Comstock; K Meador; B Hermann
Journal:  Epilepsia       Date:  1998-01       Impact factor: 5.864

2.  Epilepsy-associated stigma from the perspective of people with epilepsy and the community in Italy.

Authors:  Mario Tombini; Giovanni Assenza; Livia Quintiliani; Lorenzo Ricci; Jacopo Lanzone; Roberta De Mojà; Martina Ulivi; Vincenzo Di Lazzaro
Journal:  Epilepsy Behav       Date:  2019-07-09       Impact factor: 2.937

Review 3.  Adverse reactions to new anticonvulsant drugs.

Authors:  I C Wong; S D Lhatoo
Journal:  Drug Saf       Date:  2000-07       Impact factor: 5.606

4.  Natural history of treated childhood-onset epilepsy: prospective, long-term population-based study.

Authors:  Matti Sillanpää; Dieter Schmidt
Journal:  Brain       Date:  2006-01-09       Impact factor: 13.501

5.  The Spanish Version of the Quality-of-Life in Epilepsy Inventory (QOLIE-31): translation, validity, and reliability.

Authors:  X Torres; S Arroyo; S Araya; J de Pablo
Journal:  Epilepsia       Date:  1999-09       Impact factor: 5.864

6.  Validity and reliability of the Portuguese version of the quality of life in epilepsy inventory (QOLIE-31) for Brazil.

Authors:  Tatiana Indelicato da Silva; Rozana Mesquita Ciconelli; Neide Barreira Alonso; Auro Mauro Azevedo; Ana Carolina Westphal-Guitti; Tatiana Frascarelli Pascalicchio; Carolina Mattos Marques; Luís Otávio Sales Ferreira Caboclo; Joyce A Cramer; Américo Ceiki Sakamoto; Elza Márcia Targas Yacubian
Journal:  Epilepsy Behav       Date:  2007-02-09       Impact factor: 2.937

Review 7.  Health-related quality-of-life issues: optimizing patient outcomes.

Authors:  G A Baker
Journal:  Neurology       Date:  1995-03       Impact factor: 9.910

8.  Outcomes of add-on treatment with lamotrigine in partial epilepsy.

Authors:  D Smith; G Baker; G Davies; M Dewey; D W Chadwick
Journal:  Epilepsia       Date:  1993 Mar-Apr       Impact factor: 5.864

Review 9.  Cognitive effects of seizures.

Authors:  Guy Vingerhoets
Journal:  Seizure       Date:  2006-03-20       Impact factor: 3.184

10.  Measuring the impact of epilepsy: the development of a novel scale.

Authors:  A Jacoby; G Baker; D Smith; M Dewey; D Chadwick
Journal:  Epilepsy Res       Date:  1993-09       Impact factor: 3.045

View more
  6 in total

1.  Multimorbidity and chronic co-prescription networks and potential interactions in adult patients with epilepsy: MorbiNet study.

Authors:  Ferran Moratalla-Navarro; Victor Moreno; Flora López-Simarro; Maria Estrella Barceló; Alba Aguado
Journal:  Neurol Sci       Date:  2022-09-05       Impact factor: 3.830

2.  Theory of Mind and Empathy in Adults With Epilepsy: A Meta-Analysis.

Authors:  HongZhou Wang; PanWen Zhao; Jing Zhao; JianGuo Zhong; PingLei Pan; GenDi Wang; ZhongQuan Yi
Journal:  Front Psychiatry       Date:  2022-04-27       Impact factor: 5.435

3.  Comparison of Long-Term Outcomes of Monotherapy and Polytherapy in Seizure-Free Patients With Epilepsy Following Antiseizure Medication Withdrawal.

Authors:  Yuxuan Wang; Li Xia; Rong Li; Yudan Li; Jingyi Li; Qin Zhou; Songqing Pan
Journal:  Front Neurol       Date:  2021-05-24       Impact factor: 4.003

4.  Felt Stigma and Its Underlying Contributors in Epilepsy Patients.

Authors:  Lingyan Mao; Keying Wang; Qianqian Zhang; Jing Wang; Yanan Zhao; Weifeng Peng; Jing Ding
Journal:  Front Public Health       Date:  2022-04-26

5.  Patient complexity, depression, and quality of life in patients with epilepsy at an epilepsy center in Japan.

Authors:  Yasuiro Kishi; Ichiro Takumi; Hitoshi Yamamoto; Takako Ishimaru; Steven Thurber
Journal:  Epilepsia Open       Date:  2022-05-31

6.  Perceived epilepsy-related stigma is linked to the socioeconomic status of the residence.

Authors:  Louisa Hohmann; Justus Berger; Shirley-Uloma Kastell; Martin Holtkamp
Journal:  Front Public Health       Date:  2022-08-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.